Extent of Surgical Injury Is Associated with Rate of Enoxaparin Metabolism: An Examination of Anti-Factor Xa Levels in Lower Extremity Free Flap Patients

Madison Hunt; Christopher J. Pannucci

doi:10.1055/s-0037-1601446

Journal of Reconstructive Microsurgery Open, Table of Contents

CC-BY-NC-ND 4.0 · J Reconstr Microsurg Open 2017; 02(01): e26-e28
DOI: 10.1055/s-0037-1601446

Letter to the Editor: Short Report

Thieme Medical Publishers, Inc. 333 Seventh Avenue, New York, NY 10001, USA

Extent of Surgical Injury Is Associated with Rate of Enoxaparin Metabolism: An Examination of Anti-Factor Xa Levels in Lower Extremity Free Flap Patients

Madison Hunt

¹Division of Plastic Surgery, University of Utah, Salt Lake City, Utah

,

Christopher J. Pannucci

¹Division of Plastic Surgery, University of Utah, Salt Lake City, Utah

²Division of Health Services Research, University of Utah, Salt Lake City, Utah

› Author Affiliations

Abstract

Full Text

References

References
1 Office of the Surgeon General (US); National Heart, Lung, and Blood Institute (US). The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville, MD: Office of the Surgeon General (US; 2008. Available at: https://www.ncbi.nlm.nih.gov/books/NBK44178 . Accessed November 4, 2016
2 Berndtson AE, Costantini TW, Lane J, Box K, Coimbra R. If some is good, more is better: An enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis. J Trauma Acute Care Surg 2016; 81 (06) 1095-1100
3 Ricci JA, Crawford K, Ho OA, Lee BT, Patel KM, Iorio ML. Practical Guidelines for Venous Thromboembolism Prophylaxis in Free Tissue Transfer. Plast Reconstr Surg 2016; 138 (05) 1120-1131
4 Lin H, Faraklas I, Cochran A, Saffle J. Enoxaparin and antifactor Xa levels in acute burn patients. J Burn Care Res 2011; 32 (01) 1-5
5 Pannucci CJ, Rockwell WB, Ghanem M. , et al. Inadequate enoxaparin dosing predicts 90-day venous thromboembolism risk among plastic surgery inpatients: an examination of enoxaparin pharmacodynamics. Plast Reconstr Surg 2016;
6 Faraklas I, Ghanem M, Brown A, Cochran A. Evaluation of an enoxaparin dosing calculator using burn size and weight. J Burn Care Res 2013; 34 (06) 621-627
7 Chapman SA, Irwin ED, Reicks P, Beilman GJ. Non-weight-based enoxaparin dosing subtherapeutic in trauma patients. J Surg Res 2016; 201 (01) 181-187
8 Ludwig KP, Simons HJ, Mone M, Barton RG, Kimball EJ. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients. Ann Pharmacother 2011; 45 (11) 1356-1362
9 Pannucci CJ, Prazak AM, Scheefer M. Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis. Am J Surg 2016;
10 Iannuzzi JC, Young KC, Kim MJ, Gillespie DL, Monson JR, Fleming FJ. Prediction of postdischarge venous thromboembolism using a risk assessment model. J Vasc Surg 2013; 58 (04) 1014-1020.e1